245 related articles for article (PubMed ID: 11999464)
1. Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone.
Erbersdobler A; Fritz H; Schnöger S; Graefen M; Hammerer P; Huland H; Henke RP
Eur Urol; 2002 Jan; 41(1):40-6. PubMed ID: 11999464
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones.
Sakai I; Harada K; Hara I; Eto H; Miyake H
BJU Int; 2005 Sep; 96(4):528-32. PubMed ID: 16104904
[TBL] [Abstract][Full Text] [Related]
3. Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour.
Shannon BA; McNeal JE; Cohen RJ
Pathology; 2003 Dec; 35(6):467-71. PubMed ID: 14660095
[TBL] [Abstract][Full Text] [Related]
4. Detection of apoptosis by the TUNEL technique in clinically localised prostatic cancer before and after combined endocrine therapy.
Colecchia M; Frigo B; Del Boca C; Guardamagna A; Zucchi A; Colloi D; Leopardi O
J Clin Pathol; 1997 May; 50(5):384-8. PubMed ID: 9215120
[TBL] [Abstract][Full Text] [Related]
5. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence.
O'Neil LM; Walsh S; Cohen RJ; Lee S
BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868
[TBL] [Abstract][Full Text] [Related]
6. Differences in biopsy features between prostate cancers located in the transition and peripheral zone.
Augustin H; Erbersdobler A; Graefen M; Jaekel T; Haese A; Huland H; Hammerer PG
BJU Int; 2003 Apr; 91(6):477-81. PubMed ID: 12656897
[TBL] [Abstract][Full Text] [Related]
7. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
Sakai I; Harada K; Kurahashi T; Yamanaka K; Hara I; Miyake H
Int J Urol; 2006 Apr; 13(4):368-72. PubMed ID: 16734852
[TBL] [Abstract][Full Text] [Related]
8. Does benign prostatic hyperplasia originate from the peripheral zone of the prostate? A preliminary study.
Tang J; Yang JC; Zhang Y; Liu X; Zhang L; Wang Z; Li J; Luo Y; Xu J; Shi H
BJU Int; 2007 Nov; 100(5):1091-6. PubMed ID: 17922787
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer.
Amirghofran Z; Monabati A; Gholijani N
Pathol Oncol Res; 2004; 10(1):37-41. PubMed ID: 15029260
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer.
Häussler O; Epstein JI; Amin MB; Heitz PU; Hailemariam S
Hum Pathol; 1999 Sep; 30(9):1077-86. PubMed ID: 10492043
[TBL] [Abstract][Full Text] [Related]
11. Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis.
Greene DR; Wheeler TM; Egawa S; Weaver RP; Scardino PT
Br J Urol; 1991 Nov; 68(5):499-509. PubMed ID: 1747726
[TBL] [Abstract][Full Text] [Related]
12. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
[TBL] [Abstract][Full Text] [Related]
13. Abnormal expression of MDM2 in prostate carcinoma.
Leite KR; Franco MF; Srougi M; Nesrallah LJ; Nesrallah A; Bevilacqua RG; Darini E; Carvalho CM; Meirelles MI; Santana I; Camara-Lopes LH
Mod Pathol; 2001 May; 14(5):428-36. PubMed ID: 11353053
[TBL] [Abstract][Full Text] [Related]
14. Pathological and clinical characteristics of large prostate cancers predominantly located in the transition zone.
Erbersdobler A; Huhle S; Palisaar J; Graefen M; Hammerer P; Noldus J; Huland H
Prostate Cancer Prostatic Dis; 2002; 5(4):279-84. PubMed ID: 12627212
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of prostate cancer originating from the transition zone.
King CR; Ferrari M; Brooks JD
Urol Oncol; 2009; 27(6):592-7. PubMed ID: 18799332
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological study of prostate cancer patients who had a serum PSA level of more than 20 ng/ml and were treated by a radical prostatectomy].
Udo K; Otsubo S; Sakamoto N; Iguchi A
Nihon Hinyokika Gakkai Zasshi; 2007 Jul; 98(5):685-90. PubMed ID: 17682447
[TBL] [Abstract][Full Text] [Related]
17. Relationship between apoptosis regulator proteins (bcl-2 and p53) and Gleason score in prostate cancer.
Karaburun Paker S; Kilicarslan B; Ciftcioglu AM; Oztekin S; Sargin FC; Erdogru T; Baykara M
Pathol Oncol Res; 2001; 7(3):209-12. PubMed ID: 11692148
[TBL] [Abstract][Full Text] [Related]
18. Numerical chromosomal aberrations in transition-zone carcinomas of the prostate.
Erbersdobler A; Hammerer P; Huland H; Henke RP
J Urol; 1997 Oct; 158(4):1594-8. PubMed ID: 9302180
[TBL] [Abstract][Full Text] [Related]
19. Biochemical recurrence following radical prostatectomy: a comparison between prostate cancers located in different anatomical zones.
Augustin H; Erbersdobler A; Graefen M; Fernandez S; Palisaar J; Huland H; Hammerer P
Prostate; 2003 Apr; 55(1):48-54. PubMed ID: 12640660
[TBL] [Abstract][Full Text] [Related]
20. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia.
Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K
J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]